Search
for
Sort by
Research 121–150 of 776
- Application of Baricitinib in Dermatology
- Psychological Stress-Induced Pathogenesis of Alopecia Areata: Autoimmune and Apoptotic Pathways
- Baricitinib: A Review in Severe Alopecia Areata
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata
- Comparative analysis of therapeutic outcomes in pediatric versus adult ophiasis-pattern alopecia areata: A review of treatment modalities and disease course
- Hair regrowth in a patient with central centrifugal cicatricial alopecia after a 2-month trial of baricitinib
- Safety and efficacy of tofacitinib in 97 alopecia areata patients
- Combination of baricitinib and conventional immunomodulating therapy for alopecia totalis
- Inibidores das Janus Associated Kinases na Terapêutica Farmacológica
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- Hair regrowth in alopecia areata and re‐pigmentation in vitiligo in response to treatment: Commonalities and differences
- Treatment of Crohn's Disease and Concomitant Alopecia Areata With Tofacitinib
- Dual Relief: How Atopic Dermatitis Treatments Affect Alopecia Areata—A Small Retrospective Cohort Study
- Drug Armamentarium for alopecia areata
- Efficacy of Tofacitinib in the Treatment of Universal Alopecia Areata and Primary Sjögren Syndrome
- Baricitinib in pediatric chronic immune thrombocytopenia and associated autoimmune conditions: a case report
- Continued treatment with baricitinib results in meaningful scalp responses among scalp non‐responder patients with eyebrow/eyelash regrowth in the first year
- Tratamiento de la alopecia areata, un recorrido desde las opciones terapéuticas clásicas hasta los nuevos fármacos aparecidos en los últimos años
- Real-world Burden of Disease and Clinical Characteristics of Alopecia Areata Among Adults in Brazil: Results from a Cross-sectional Survey
- Evaluation of the level of serum Interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata
- JAK-centric explainable few-shot gene-expression diagnosis framework for alopecia via MultiPLIER priors and relation-style set-to-set comparison
- A Subset of TREM2+ Dermal Macrophages Secretes Oncostatin M to Maintain Hair Follicle Stem Cell Quiescence and Inhibit Hair Growth
- Selective Delivery of Tofacitinib Citrate to Hair Follicles Using Lipid-Coated Calcium Carbonate Nanocarrier Controls Chemotherapy-Induced Alopecia Areata
- 013 IL-15/IL-15Rα signaling is a guardian of human hair follicle immune privilege and promotes hair growth
- 397 Predictive modeling of drug response and mechanism of action in alopecia areata clinical trials
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- INVESTIGATING THE MECHANISMS UNDERLYING THE PATHOGENESIS OF ALOPECIA AREATA
- Switching between tofacitinib and baricitinib in alopecia areata: A review of clinical response